The sick building syndrome. I. Definition and epidemiological considerations

Christopher C. Chang, Ronald A. Ruhl, Georges M. Halpern, M. Eric Gershwin

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

It has been difficult to confirm that a given building is responsible for allergic symptomatology, exacerbation of asthma, or immunological dysfunction. In fact, in most studies, few objective immunological parameters have been studied and only rarely has there been any quantitation of IgE or secondary mediators. Furthermore, although many studies deal with rhinitis or respiratory tract irritation, there is a misconception that all such symptoms are allergic in nature, and studies attempting to prove that allergies are caused by buildings frequently neglect to prove that these are indeed true allergic responses. In addition, many of the symptoms that people attribute to sick building syndrome (SBS) or building-related illness, such as headaches, dizziness, fatigue, nausea, cough, and eye irritation, are subjective, and studies often fail to take into account other possible causes that may be inherent in the subjects, such as sinusitis, hyperventilation syndrome, or psychosomatic illness. Unfortunately, most clinical studies on SBS pay little attention to the preexisting conditions that a subject may have and discount the possibility that the inciting agent does not cause symptoms, but merely exacerbates a preexisting condition. Moreover, they offer no information about the nature of the mechanisms of action or pathophysiological relationships. Clearly, further studies are necessary to further explain the complexity of complaints that currently exist. Indeed, SBS might properly be paraphrased as "What is it?-if it is!rdquo;.

Original languageEnglish (US)
Pages (from-to)285-295
Number of pages11
JournalJournal of Asthma
Volume30
Issue number4
DOIs
StatePublished - 1993

Fingerprint

Sick Building Syndrome
Preexisting Condition Coverage
Hyperventilation
Sinusitis
Dizziness
Rhinitis
Cough
Respiratory System
Nausea
Immunoglobulin E
Fatigue
Headache
Hypersensitivity
Asthma

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Immunology and Allergy
  • Pediatrics, Perinatology, and Child Health

Cite this

The sick building syndrome. I. Definition and epidemiological considerations. / Chang, Christopher C.; Ruhl, Ronald A.; Halpern, Georges M.; Gershwin, M. Eric.

In: Journal of Asthma, Vol. 30, No. 4, 1993, p. 285-295.

Research output: Contribution to journalArticle

Chang, Christopher C. ; Ruhl, Ronald A. ; Halpern, Georges M. ; Gershwin, M. Eric. / The sick building syndrome. I. Definition and epidemiological considerations. In: Journal of Asthma. 1993 ; Vol. 30, No. 4. pp. 285-295.
@article{01643a62ac3841fc90e8d101004ea2f3,
title = "The sick building syndrome. I. Definition and epidemiological considerations",
abstract = "It has been difficult to confirm that a given building is responsible for allergic symptomatology, exacerbation of asthma, or immunological dysfunction. In fact, in most studies, few objective immunological parameters have been studied and only rarely has there been any quantitation of IgE or secondary mediators. Furthermore, although many studies deal with rhinitis or respiratory tract irritation, there is a misconception that all such symptoms are allergic in nature, and studies attempting to prove that allergies are caused by buildings frequently neglect to prove that these are indeed true allergic responses. In addition, many of the symptoms that people attribute to sick building syndrome (SBS) or building-related illness, such as headaches, dizziness, fatigue, nausea, cough, and eye irritation, are subjective, and studies often fail to take into account other possible causes that may be inherent in the subjects, such as sinusitis, hyperventilation syndrome, or psychosomatic illness. Unfortunately, most clinical studies on SBS pay little attention to the preexisting conditions that a subject may have and discount the possibility that the inciting agent does not cause symptoms, but merely exacerbates a preexisting condition. Moreover, they offer no information about the nature of the mechanisms of action or pathophysiological relationships. Clearly, further studies are necessary to further explain the complexity of complaints that currently exist. Indeed, SBS might properly be paraphrased as {"}What is it?-if it is!rdquo;.",
author = "Chang, {Christopher C.} and Ruhl, {Ronald A.} and Halpern, {Georges M.} and Gershwin, {M. Eric}",
year = "1993",
doi = "10.3109/02770909309054529",
language = "English (US)",
volume = "30",
pages = "285--295",
journal = "Journal of Asthma",
issn = "0277-0903",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - The sick building syndrome. I. Definition and epidemiological considerations

AU - Chang, Christopher C.

AU - Ruhl, Ronald A.

AU - Halpern, Georges M.

AU - Gershwin, M. Eric

PY - 1993

Y1 - 1993

N2 - It has been difficult to confirm that a given building is responsible for allergic symptomatology, exacerbation of asthma, or immunological dysfunction. In fact, in most studies, few objective immunological parameters have been studied and only rarely has there been any quantitation of IgE or secondary mediators. Furthermore, although many studies deal with rhinitis or respiratory tract irritation, there is a misconception that all such symptoms are allergic in nature, and studies attempting to prove that allergies are caused by buildings frequently neglect to prove that these are indeed true allergic responses. In addition, many of the symptoms that people attribute to sick building syndrome (SBS) or building-related illness, such as headaches, dizziness, fatigue, nausea, cough, and eye irritation, are subjective, and studies often fail to take into account other possible causes that may be inherent in the subjects, such as sinusitis, hyperventilation syndrome, or psychosomatic illness. Unfortunately, most clinical studies on SBS pay little attention to the preexisting conditions that a subject may have and discount the possibility that the inciting agent does not cause symptoms, but merely exacerbates a preexisting condition. Moreover, they offer no information about the nature of the mechanisms of action or pathophysiological relationships. Clearly, further studies are necessary to further explain the complexity of complaints that currently exist. Indeed, SBS might properly be paraphrased as "What is it?-if it is!rdquo;.

AB - It has been difficult to confirm that a given building is responsible for allergic symptomatology, exacerbation of asthma, or immunological dysfunction. In fact, in most studies, few objective immunological parameters have been studied and only rarely has there been any quantitation of IgE or secondary mediators. Furthermore, although many studies deal with rhinitis or respiratory tract irritation, there is a misconception that all such symptoms are allergic in nature, and studies attempting to prove that allergies are caused by buildings frequently neglect to prove that these are indeed true allergic responses. In addition, many of the symptoms that people attribute to sick building syndrome (SBS) or building-related illness, such as headaches, dizziness, fatigue, nausea, cough, and eye irritation, are subjective, and studies often fail to take into account other possible causes that may be inherent in the subjects, such as sinusitis, hyperventilation syndrome, or psychosomatic illness. Unfortunately, most clinical studies on SBS pay little attention to the preexisting conditions that a subject may have and discount the possibility that the inciting agent does not cause symptoms, but merely exacerbates a preexisting condition. Moreover, they offer no information about the nature of the mechanisms of action or pathophysiological relationships. Clearly, further studies are necessary to further explain the complexity of complaints that currently exist. Indeed, SBS might properly be paraphrased as "What is it?-if it is!rdquo;.

UR - http://www.scopus.com/inward/record.url?scp=0027186252&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027186252&partnerID=8YFLogxK

U2 - 10.3109/02770909309054529

DO - 10.3109/02770909309054529

M3 - Article

C2 - 8331040

AN - SCOPUS:0027186252

VL - 30

SP - 285

EP - 295

JO - Journal of Asthma

JF - Journal of Asthma

SN - 0277-0903

IS - 4

ER -